ALGN Stock Recent News

Align Technology, Inc. holds dominant market share in clear aligners and related hardware/software, with strong international growth potential despite recent U.S. demand softness. Current revenue and margin pressures are largely macro-driven and cyclical; management is proactively cutting costs and optimizing operations to maintain profitability. The company boasts a robust balance sheet, healthy cash flow, and is trading at historically low valuation multiples, offering an attractive risk-reward profile.

TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it is planning to repurchase $200 million of Align's common stock through open market repurchases under Align's $1.0 billion stock repurchase program that was approved by.

SAN DIEGO, Aug. 04, 2025 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving Align Technology, Inc. (NASDAQ: ALGN) focused on whether Align Technology and certain of its top executives made false and/or misleading statements and/or failed to disclose material information to investors.

Align Technology shares plunged last after Q2 results were posted. They are now down some 55% from my Sell rating on the stock early in 2024. It should be noted that the company boasts a strong balance sheet with $900M in cash, no long-term debt, solid free cash flow, and a $1B buyback authorization. The CEO of the company also stepped up and purchased nearly $1M in shares after last week's decline.

TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that Joe Hogan, Align Technology president and CEO, has personally purchased approximately $1 million of Align's common stock. Since his last sale of Align common stock in 2021.

SAN DIEGO , Aug. 1, 2025 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving Align Technology, Inc. (NASDAQ: ALGN) focused on whether Align Technology and certain of its top executives made false and/or misleading statements and/or failed to disclose material information to investors. If you have information that could assist in the Align Technology investigation or if you are an Align Technology investor who suffered a loss and would like to learn more, you can provide your information here: https://www.rgrdlaw.com/cases-align-technology-inc-investigation-algn.html You can also contact attorneys J.C.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Align Technology (ALGN) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

Major U.S. equity indexes moved lower on Thursday after the latest Personal Consumption Expenditures (PCE) data showed inflation accelerated in June, offsetting strong Big Tech earnings. Several economists attributed the higher-than-expected reading for the PCE, the Federal Reserve's preferred inflation gauge, to tariff pressures.

Align Technology (ALGN) was the worst-performing stock in the S&P 500 Thursday, losing more than a third of its value a day after the Invisalign maker reported second-quarter results that missed analysts' expectations and announced a restructuring.